XENE
Xenon Pharmaceuticals Inc
37.60$
-1.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.20 | 10.75 | 2.78 | 2.04 | 1.09 | 0.12 | 0.02 | 0.00 | 0.26 | 0.93 | 0.42 | 0.16 | 0.00 | 0.00 | 0.09 | |
| – | 5.50 | 0.63 | 0.42 | 0.19 | 0.07 | 1.42 | 0.31 | 1.50 | 1.46 | 1.73 | 1.75 | 2.50 | 0.03 | 0.03 | |
| 5.20 | 5.25 | 2.15 | 1.62 | 1.09 | 0.04 | -1.40 | -0.31 | 0.26 | 0.93 | 0.42 | 0.16 | -2.50 | -0.03 | 0.06 | |
| 9.26 | 7.85 | 1.25 | 0.85 | 1.06 | 1.28 | 1.42 | 1.22 | 1.50 | 1.46 | 1.73 | 1.75 | 2.50 | 2.70 | 3.80 | |
| 5.06 | 5.26 | 0.54 | 0.40 | 0.69 | 0.44 | 0.41 | 0.43 | 0.42 | 0.37 | 0.50 | 0.54 | 0.70 | 0.88 | 1.00 | |
| 14.32 | 13.12 | 1.80 | 1.24 | 1.75 | 1.72 | 1.83 | 1.65 | 1.91 | 1.84 | 2.23 | 2.29 | 0.70 | 3.55 | 4.77 | |
| -9.11 | -2.37 | 0.99 | 0.80 | -0.66 | -1.60 | -1.81 | -1.96 | -1.65 | -0.91 | -1.81 | -2.13 | -3.20 | -3.59 | -4.71 | |
| 0.07 | 0.07 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.06 | 0.01 | 0.02 | 0.09 | – | – | – | |
| -9.02 | -3.23 | 1.22 | 0.94 | -1.10 | -1.48 | -1.71 | -1.78 | -1.60 | -0.84 | -1.81 | -2.07 | -2.73 | -3.06 | -4.35 | |
| 0.07 | 0.07 | 0.01 | 0.00 | -0.07 | -0.12 | -0.10 | 0.25 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | -0.05 | 0.01 | |
| -9.02 | -3.23 | 1.22 | 0.94 | -1.10 | -1.48 | -1.71 | -1.78 | -1.60 | -0.83 | -1.81 | -2.07 | -2.73 | -3.01 | -4.36 | |
| -8.10 | -2.57 | 1.06 | 0.85 | -0.58 | -1.55 | -1.67 | -1.68 | -1.53 | -0.89 | -1.79 | -2.11 | -3.15 | -3.03 | -4.32 |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.